AI in Healthcare: Diagnostics, Drug Discovery, and Robotics

Status: public · Confidence: high (0.865) · Basis: verified_sources

## TL;DR

AI in healthcare includes medical imaging, screening support, device software, clinical workflow tools, and research systems. Public claims should separate research results from regulatory authorization.

## Core Explanation

This repaired entry keeps claims tied to CheXNet, a Nature breast-screening evaluation, and the FDA's official AI-enabled medical-device list.

## Detailed Analysis

The previous version mixed research, drug discovery, robotics, and changing device counts under broad claims. Exact device totals and product-category shares should be refreshed from the FDA list when needed rather than hard-coded here.

## Further Reading

- [CheXNet](https://arxiv.org/abs/1711.05225)
- [Nature: AI system for breast cancer screening](https://www.nature.com/articles/s41586-019-1799-6)
- [FDA: Artificial Intelligence-Enabled Medical Devices](https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices)

## Related Articles

- [AI for Drug Discovery: Molecular Docking, Virtual Screening, and De Novo Design](../ai-for-drug-discovery-molecular-docking-virtual-screening-and-de-novo-design.md)
- [AI for Drug Discovery: AlphaFold, Molecular Generation, and Generative Chemistry](../ai-for-drug-discovery.md)
- [AI Digital Twins for Healthcare: Patient-Specific Simulation, Treatment Planning, and Virtual Organs](../ai-digital-twins-healthcare.md)